Cargando…

HSP27 phosphorylation inhibitor regulates Her2 expression in human breast cancer cell line SK-BR-3 with induced Herceptin resistance

Detalles Bibliográficos
Autores principales:	Kim, Min Kyung, Kim, Seung Cheol, Kim, Won Ki, Kim, Kun, Kim, Kyung-Hee, Yoo, Byong Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125859/ http://dx.doi.org/10.1186/1878-5085-5-S1-A47

Ejemplares similares

Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability
por: Kang, Se Hun, et al.
Publicado: (2008)

CD133-regulated nucleophosmin expression in human colon cancer cells
por: Kim, Kun, et al.
Publicado: (2014)

Serological Her2/neu-determination in patients receiving Herceptin(®)
por: Thomas, A, et al.
Publicado: (2001)

Herceptin clinical trials: past, present and future
por: Vogel, CL
Publicado: (2001)

Specific Roles of HSP27 S15 Phosphorylation Augmenting the Nuclear Function of HER2 to Promote Trastuzumab Resistance
por: Hwang, Soo-Yeon, et al.
Publicado: (2020)

HER2 Phosphorylation Is Maintained by a PKB Negative Feedback Loop in Response to Anti-HER2 Herceptin in Breast Cancer
por: Gijsen, Merel, et al.
Publicado: (2010)

Herceptin (trastuzumab) in patients who overexpress Her-2 and have failed multiple chemotherapy regimens for advanced breast cancer: a pragmatic study
por: Westman, G
Publicado: (2000)

Correction: HER2 Phosphorylation Is Maintained by a PKB Negative Feedback Loop in Response to Anti-HER2 Herceptin in Breast Cancer
por: Gijsen, Merel, et al.
Publicado: (2016)

Psoriasis Induced by Trastuzumab (Herceptin®)
por: Kim, Dae Hun, et al.
Publicado: (2013)

Herceptin-sensitivity of HER2-transgenic mouse mammary tumors
por: Schwall, RH, et al.
Publicado: (2003)

Mechanism of anti-tumor and anti-invasive function of SOCS isoform in colon cancer models
por: Kim, Won Ki, et al.
Publicado: (2014)

113: SPECIFIC TARGETING OF HER2-POSITIVE BREAST CANCER CELL LINE (SK-BR3) USING IDARUBICIN-LOADED ANTI-HER2 IMMUNOLIPOSOME
por: Pourshohod, Aminollah, et al.
Publicado: (2017)

Differential levels of L-homocysteic acid and lysophosphatidylcholine (16:0) in sera of patients with ovarian cancer
por: KIM, SEUNG CHEOL, et al.
Publicado: (2014)

Repetitive Nerve Stimulation in MuSK-Antibody-Positive Myasthenia Gravis
por: Kim, Seung Woo, et al.
Publicado: (2017)

Myricetin induces apoptosis through the MAPK pathway and regulates JNK-mediated autophagy in SK-BR-3 cells
por: Han, So-Hee, et al.
Publicado: (2022)

Update on HER-2 as a target for cancer therapy: Herceptin in the clinical setting
por: Miles, David W
Publicado: (2001)

Phosphorylation of Ser(78 )of Hsp27 correlated with HER-2/neu status and lymph node positivity in breast cancer
por: Zhang, Daohai, et al.
Publicado: (2007)

Anticancer Effect of Metformin in Herceptin-Conjugated Liposome for Breast Cancer
por: Lee, Ji-Yeon, et al.
Publicado: (2019)

Plantar pressure distribution during treadmill walking in comfort shoes with PLA(Poly Lactic Acid) resins
por: Park, Seung-Bum, et al.
Publicado: (2014)

Biomechanical analysis of smart walking shoe sending movement information to display device by radio communication
por: Park, Seung-Bum, et al.
Publicado: (2014)

An analysis of functional insole on foot pressure distribution of shape memory material combinations
por: Park, Seung-Bum, et al.
Publicado: (2014)

Biomechanical analysis of marathon shoes applied to NESTFIT technology
por: Park, Seung-Bum, et al.
Publicado: (2014)

HSP27 inhibitor attenuates radiation-induced pulmonary inflammation
por: Kim, Jee-Youn, et al.
Publicado: (2018)

Presence of HER4 associates with increased sensitivity to Herceptin™ in patients with metastatic breast cancer
por: Sassen, Andrea, et al.
Publicado: (2009)

Kinetic Modeling of DUSP Regulation in Herceptin-Resistant HER2-Positive Breast Cancer
por: Buiga, Petronela, et al.
Publicado: (2019)

Reciprocal Regulation of Annexin A2 and EGFR with Her-2 in Her-2 Negative and Herceptin-Resistant Breast Cancer
por: Shetty, Praveenkumar K., et al.
Publicado: (2012)

Overcoming HSP27-mediated resistance by altered dimerization of HSP27 using small molecules
por: Kim, Jee Hye, et al.
Publicado: (2016)

SORBS1 serves a metastatic role via suppression of AHNAK in colorectal cancer cell lines
por: Cho, Woo-Cheol, et al.
Publicado: (2020)

Identification of calgranulin B interacting proteins and network analysis in gastrointestinal cancer cells
por: Kim, Kyung-Hee, et al.
Publicado: (2017)

Recombinant humanised anti-HER2/neu antibody (Herceptin®) induces cellular death of glioblastomas
por: Mineo, J-F, et al.
Publicado: (2004)

Overexpression of mutant HSP27 causes axonal neuropathy in mice
por: Lee, Jinho, et al.
Publicado: (2015)

Correction: Reciprocal Regulation of Annexin A2 and EGFR with Her-2 in Her-2 Negative and Herceptin-Resistant Breast Cancer
por: Shetty, Praveenkumar K., et al.
Publicado: (2012)

Tyrosine 23 Phosphorylation of Annexin A2 Promotes Proliferation, Invasion, and Stat3 Phosphorylation in the Nucleus of Human Breast Cancer SK-BR-3 Cells
por: Wang, Yu-qing, et al.
Publicado: (2012)

Monocyte Proteomics Reveals Involvement of Phosphorylated HSP27 in the Pathogenesis of Osteoporosis
por: Daswani, Bhavna, et al.
Publicado: (2015)

Drifts in ADCC-related quality attributes of Herceptin®: Impact on development of a trastuzumab biosimilar
por: Kim, Seokkyun, et al.
Publicado: (2017)

Profiling of Serum Metabolites Using MALDI-TOF and Triple-TOF Mass Spectrometry to Develop a Screen for Ovarian Cancer
por: Lee, Jun Hwa, et al.
Publicado: (2018)

Plant-Made Trastuzumab (Herceptin) Inhibits HER2/Neu+ Cell Proliferation and Retards Tumor Growth
por: Komarova, Tatiana V., et al.
Publicado: (2011)

HER2 Protein Overexpression and Gene Amplification in Plasmacytoid Urothelial Carcinoma of the Urinary Bladder
por: Kim, Bohyun, et al.
Publicado: (2016)

Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance and molecular subtype conversion: clinical implications for serum HER2 in recurrent HER2-negative breast cancer
por: Kim, Yun Gyoung, et al.
Publicado: (2017)

Proteins that interact with calgranulin B in the human colon cancer cell line HCT-116
por: Myung, Jae Kyung, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0ag17q90vuu6gttft28u9rp40k